New research from Cambridge sheds light on how inheriting a mutated copy of the breast cancer gene BRCA2 increases the risk of cancers of the breast, ovary, pancreas or prostate at an early age.
New research reveals the immune system’s cancer-killing T cells are more effective in a tumour’s oxygen-starved environment when they have access to growth factor VEGF-A.